Latest: FDA Approves New Biosimilar for Oncology Treatment

Understanding Tau Aggregation in Alzheimer Disease and Related Dementias: Maria Grazia Spillantini, PhD

by Neurology Live

13 September, 2025

0 Mins

The professor of molecular neurology at the University of Cambridge highlighted recent research on tau protein aggregation in Alzheimer disease and other related tauopathies. [WATCH TIME: 6 minutes]

Tags:

Author

Neurology Live

AAIC Presentations Provide Context on Lecanemab’s Real-World Effect 2 Years Since Approval

The Scan by 2 Minute Medicine®: Fibroids, Fatigue, Tainted Syrups, and Bariatric Barriers

📢

300x250 Banner

Understanding Tau Aggregation in Alzheimer Disease and Related Dementias: Maria Grazia Spillantini, PhD

Tags:

Neurology Live

AAIC Presentations Provide Context on Lecanemab’s Real-World Effect 2 Years Since Approval

The Scan by 2 Minute Medicine®: Fibroids, Fatigue, Tainted Syrups, and Bariatric Barriers

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition